Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Medtronic
Express Scripts
Cerilliant
Deloitte
Fish and Richardson
Federal Trade Commission
Covington
Mallinckrodt
McKinsey
Cipla

Generated: August 16, 2017

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: carbamazepine

« Back to Dashboard

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Taro
CARBAMAZEPINE
carbamazepine
CAPSULE, EXTENDED RELEASE;ORAL201106ANDATaro Pharmaceuticals U.S.A., Inc.51672-4149-1120 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (51672-4149-1)
Taro
CARBAMAZEPINE
carbamazepine
CAPSULE, EXTENDED RELEASE;ORAL201106ANDATaro Pharmaceuticals U.S.A., Inc.51672-4149-31000 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (51672-4149-3)
Taro
CARBAMAZEPINE
carbamazepine
CAPSULE, EXTENDED RELEASE;ORAL201106ANDATaro Pharmaceuticals U.S.A., Inc.51672-4149-630 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (51672-4149-6)
Taro
CARBAMAZEPINE
carbamazepine
CAPSULE, EXTENDED RELEASE;ORAL201106ANDATaro Pharmaceuticals U.S.A., Inc.51672-4150-1120 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (51672-4150-1)
Taro
CARBAMAZEPINE
carbamazepine
CAPSULE, EXTENDED RELEASE;ORAL201106ANDATaro Pharmaceuticals U.S.A., Inc.51672-4150-31000 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (51672-4150-3)
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Argus Health
Cerilliant
Federal Trade Commission
US Army
Covington
Fish and Richardson
Cipla
Cantor Fitzgerald
UBS
Novartis

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot